The global stem cell therapy market is anticipated to grow at a CAGR of 15.8% during the forecast period. The ongoing developments in stem cell therapy are key factors driving the growth of the global stem cell therapy market. For instance, in July 2022, the Louisville-based National Stem Cell Foundation (NSCF) funded the first-in-kind study of neurodegeneration on the International Space Station (ISS) with a bi-coastal team of leading experts in the fields of Parkinson’s disease (PD) and multiple sclerosis (MS). The study uses organoids, 3-D aggregates of cells from PD and primary progressive MS (PPMS) patients that mimic the central nervous system, and microglia, the immune cells that have been recognized as playing a role in neurodegeneration. The project launched from Cape Canaveral on July 14 and travelled to the International Space Station for a fourth time aboard the SpaceX 25 Commercial Resupply Mission for NASA.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/stem-cell-therapy-market
In June 2022, Lifespan Cancer Institute received approval to operate an autologous stem-cell therapy program at the Lifespan Cancer Institute at Rhode Island Hospital. The approval, which was granted by the State Health Services Council in a unanimous vote on June 16, will allow patients from the institute who need cancer treatments, such as stem-cell therapy which provides bone marrow transplants for patients undergoing chemotherapy, to receive care with their regular medical team.
Market Coverage
- The market number available for – 2021-2028
- Base year- 2021
- Forecast period- 2022-2028
- Segment Covered-
o By Type
o By Therapeutic Application
o By Cell Source
- Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
- Competitive Landscape- Smith & Nephew plc, MEDIPOST Co., Ltd., and Anterogen Co., Ltd., among others.
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- How COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
- Who is the leader in the market?
- How are players addressing challenges to sustain growth?
- Where is the investment opportunity?
Global Stem Cell Therapy Market Report by Segment
By Type
- Allogeneic
- Autologous
By Therapeutic Application
- Musculoskeletal
- Wound & Injury
- CVD
- Autoimmune & Inflammatory
By Cell Source
- Tissues
- Bone Marrow
- Placenta/Umbilical Cord
A full report of Stem Cell Therapy Market is available at: https://www.omrglobal.com/industry-reports/stem-cell-therapy-market
Stem Cell Therapy Market– Segment by Region
North America
- United States
- Canada
Europe
- Germany
- United Kingdom
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Rest of Asia-Pacific
Rest of the World
- Middle East & Africa
- Latin America
Company Profiles
- Anterogen Co., Ltd.
- JCR Pharmaceuticals Co., Ltd.
- MEDIPOST Co., Ltd.
- NuVasive, Inc.
- PHARMICELL Co., Ltd.
- Smith & Nephew plc
Reasons to Buying From us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
